SlideShare a Scribd company logo
Effective interventions in ART
An overview of Cochrane Reviews
2015
Aboubakr Elnashar
Benha university Hospital, Egypt
ABOUBAKR ELNASHAR
Searching for the Best Evidence
ABOUBAKR ELNASHAR
The Cochrane Collaboration
 International collaboration
 Prepares, maintains, and disseminates systematic
reviews
 Diverse internal structure (Review Groups,
Centres, Fields, Methods Groups, the Consumer
Network)
Cochrane Library
 The current resource with the highest methodological
rigor
 $235/year or abstracts only
 www.cochrane.org
ABOUBAKR ELNASHAR
Increasingly, couples are turning to ART for help
with conceiving and ultimately giving birth to a
healthy live baby of their own.
Fertility treatments are complex, and each ART
cycle consists of several steps. If one of the steps is
incorrectly applied, the stakes are high as
conception may not occur.
With this in mind, it is important that each step of
the ART cycle is supported by good evidence from
well-designed studies.
ABOUBAKR ELNASHAR
95 systematic reviews published in The
Cochrane Library up to July 2015 were
included.
All were high quality.
32 reviews identified interventions that were
effective (n = 19) or promising (n = 13)
14 reviews identified interventions that were
either ineffective (n = 2) or possibly ineffective
(n = 12)
13 reviews were unable to draw conclusions
due to lack of evidence.
(Farquhar et al, 2015)
ABOUBAKR ELNASHAR
Results
• Effective interventions:
indicating that the review found evidence of
effectiveness (or improved safety) for an
intervention.
ABOUBAKR ELNASHAR
• Ineffective interventions:
indicating that the review found evidence of lack of
effectiveness (or reduced safety) for an
intervention.
ABOUBAKR ELNASHAR
1. Pre-ART and adjuvant strategies
Effective interventions
• Endometrial injury in women undergoing ART:
performed in the month prior to ovulation induction:
increase both LBR or OPR and CPR
(moderate quality evidence).
•No evidence of a difference between the groups in
miscarriage, multiple pregnancy or bleeding rates.
•Endometrial injury on the day of OR: lower LBR or
OPL
(low quality evidence).
(Nastri , 2015)
ABOUBAKR ELNASHAR
• Growth hormone for IVF:
in poor responders: significant improvement in LBR
(moderate quality evidence).
(Duffy 2010)
• Metformin treatment before and during IVF or
ICSI in women with PCOS:
No conclusive evidence for improved LBR
(low quality evidence).
Met increased CPR and decreased risk of OHSS
(moderate quality evidence).
(Tso, 2014)
ABOUBAKR ELNASHAR
• Surgical treatment for hydrosalpix:
laparoscopic tubal occlusion is an alternative to
laparoscopic salpingectomy in improving IVF PR
(moderate quality evidence).
(Johnson, 2010)
ABOUBAKR ELNASHAR
2. Down-regulation with agonists or antagonists
Effective interventions
• GnRHa protocols for pituitary suppression in ART:
CPR was higher when GnRHa was used in a long
protocol as compared to a short or ultra-short
protocol
(low quality evidence).
(Maheshwari 2011)
• GnRHan for ART:
Antagonist compared with long GnRHa protocols:
reduction in OHSS
No evidence of a difference in LBR
(moderate quality evidence).
(Al-Inany 2011)
ABOUBAKR ELNASHAR
• Long-term pituitary down-regulation before IVF for
women with endometriosis:
GnRHa for a period of 3-6 months prior to IVF or
ICSI: increased CPR
(very low quality evidence).
(Sallam, 2006)
ABOUBAKR ELNASHAR
3. Ovarian stimulation
Effective interventions
• Rec vs urinary gonadotrophin for ovarian
stimulation in ART:
all available gonadotrophins were equally effective
and safe.
Choice will depend upon:
availability of the product
convenience of its use
associated costs.
Any specific differences are likely to be too small to
justify further research
(high quality evidence).
(van Wely 2011)
ABOUBAKR ELNASHAR
• Long-acting FSH vs daily FSH for ART:
medium dose (150 to 180 μg) of long-acting FSH
appeared to be a safe and as effective as daily FSH
in women with unexplained subfertility.
low dose (60 to 120 μg) of long-acting FSH
compared to daily FSH: Reduced LBR
(moderate quality evidence).
(Pouwer, 2015)
ABOUBAKR ELNASHAR
4. Ovulation triggering
Effective interventions
• Rec Vs. u hCG for final oocyte maturation
triggering in IVF and ICSI cycles:
u hCG remains the best choice for final oocyte
maturation triggering in ART
{availability and cost}
(moderate quality evidence).
(Youssef, 2011)
ABOUBAKR ELNASHAR
• GnRHa Vs. hCG for oocyte triggering in
antagonist ART cycles:
GnRHa:
lower LBR
reduced OPR
higher miscarriage rate
reduction in OHSS rates
A trade off between benefits and harms (moderate
quality evidence).
(Youssef , 2014)
ABOUBAKR ELNASHAR
5. Oocyte retrieval
Effective interventions
• Pain relief:
5 different categories of conscious sedation and
analgesia appeared to be acceptable and were
associated with a high degree of satisfaction in
women.
The optimal method may be individualised
depending on
preferences of the women and their clinicians
resource availability
(very low quality evidence).
(Kwan , 2013)
ABOUBAKR ELNASHAR
Ineffective interventions
• Follicular flushing:
No improved C or OPR
No increase in oocyte yield.
Increase operative time
More opiate analgesia
(moderate quality evidence).
(Wongtra-ngan 2010)
ABOUBAKR ELNASHAR
6. Laboratory phase
Effective interventions
• Low oxygen concentrations for embryo culture in
ART:
:an increase in LBR
(moderate quality evidence).
(Bontekoe , 2012)
ABOUBAKR ELNASHAR
Ineffective interventions
• Preimplantation genetic screening for abnormal
number of chromosomes (aneuploidies):
using fluorescent in situ hybridization significantly
decreased LBR in women of advanced maternal
age and those with repeated IVF failure
Trials in which PGS was offered to women with a
good prognosis suggested similar outcomes
(moderate quality evidence).
(Twisk, 2006)
ABOUBAKR ELNASHAR
7. Embryo transfer
Effective interventions
• Ultrasound versus ’clinical touch’ for catheter
guidance:
significant increase in CPR
(low quality evidence).
(Brown, 2010)
ABOUBAKR ELNASHAR
• Adherence compounds in ET media for ART:
use of hyaluronic acid.
improved LBR and CPR with the
Increase Multiple pregnancy rates
(moderate quality evidence).
(Bontekoe, 2014)
ABOUBAKR ELNASHAR
• Number of embryos for transfer:
single embryo transfer compared with double
embryo transfer
 LBR was lower
 fewer multiple pregnancies
(high quality evidence).
cumulative LBR associated with single embryo
transfer followed by a single frozen and thawed ET
was comparable with that after one cycle of double
embryo transfer
(low quality evidence).
(Pandian, 2013)
ABOUBAKR ELNASHAR
8. Luteal phase support
Effective interventions
• LPS:
Progesterone appears to be the best method,
higher LBR and OPR than placebo
lower rates of OHSS than hCG.
Addition of one or more doses of GnRHa to
progesterone:
higher LBR and OPR than progesterone alone.
ABOUBAKR ELNASHAR
Addition of oestrogen or hCG did not improve
outcomes, and hCG was associated with higher risk
of OHSS.
The route of progesterone administration did not
seem to matter
(quality of evidence low for most comparisons).
(van der Linden, 2015)
ABOUBAKR ELNASHAR
9. Prevention of OHSS
Effective interventions
•hydroxyethyl starch
decreased the incidence of severe OHSS
(very low quality evidence)
(Youssef 2011)
• Cabergoline:
reduce the risk of OHSS in high risk women,
especially for moderate OHSS
did not affect CPR or miscarriage rates
No increased risk of other adverse events
(low quality evidence).
(Tang, 2012)
ABOUBAKR ELNASHAR
• GnRHan compared with long GnRHa protocols:
reduction in OHSS
no evidence of a difference in LBR
(moderate quality evidence).
(Al-Inany, 2011)
ABOUBAKR ELNASHAR
• GnRHa versus hCG for oocyte triggering in
antagonist ART cycles:
lower LBR
reduced OPR
higher miscarriage rate
reduction in OHSS rates
a trade off between benefits and harms
(moderate quality evidence).
(Youssef , 2014)
ABOUBAKR ELNASHAR
C O N C L U S I O N S
This overview provides the most up to date
evidence on ART cycles from systematic reviews of
RCT
Fertility treatments are costly and the stakes are
high.
Best practice requires using the best available
evidence to optimise outcomes.
The evidence from this overview could be used to
develop clinical practice guidelines and protocols for
use in daily clinical practice, in order to improve
LBR and reduce rates of multiple pregnancy, cycle
cancellation and OHSS.
ABOUBAKR ELNASHAR

More Related Content

What's hot

Aromatase inhibitors in infertility
Aromatase inhibitors in infertilityAromatase inhibitors in infertility
Aromatase inhibitors in infertility
Aboubakr Elnashar
 
Progestogens in obstetrics: Which type and route????
Progestogens in obstetrics: Which type and route????Progestogens in obstetrics: Which type and route????
Progestogens in obstetrics: Which type and route????
Aboubakr Elnashar
 
Clomiphene citrate or aromatase inhibitors for superovulation in women with u...
Clomiphene citrate or aromatase inhibitors for superovulation in women with u...Clomiphene citrate or aromatase inhibitors for superovulation in women with u...
Clomiphene citrate or aromatase inhibitors for superovulation in women with u...
Aboubakr Elnashar
 
Obesity and ART
Obesity and ARTObesity and ART
Obesity and ART
Aboubakr Elnashar
 
Clomiphene citrate adjunctives & alternatives
Clomiphene citrate  adjunctives & alternatives Clomiphene citrate  adjunctives & alternatives
Clomiphene citrate adjunctives & alternatives
Aboubakr Elnashar
 
Treatment of poor responders: Review of Systematic reviews 2016
Treatment of poor responders: Review of Systematic reviews 2016 Treatment of poor responders: Review of Systematic reviews 2016
Treatment of poor responders: Review of Systematic reviews 2016
Aboubakr Elnashar
 
Prediction of pregnancy outcome after ICSI
Prediction  of pregnancy outcome  after ICSIPrediction  of pregnancy outcome  after ICSI
Prediction of pregnancy outcome after ICSI
Aboubakr Elnashar
 
The Role of Aromatase Inhibitors in Assisted Reproductive Technologies
The Role of Aromatase Inhibitors in Assisted Reproductive TechnologiesThe Role of Aromatase Inhibitors in Assisted Reproductive Technologies
The Role of Aromatase Inhibitors in Assisted Reproductive Technologies
Ulun Uluğ
 
Progesterone rise on the day of hcg administration (ppremature luteinization)...
Progesterone rise on the day of hcg administration (ppremature luteinization)...Progesterone rise on the day of hcg administration (ppremature luteinization)...
Progesterone rise on the day of hcg administration (ppremature luteinization)...
Aboubakr Elnashar
 
Role of GnRH agonist in benign gynaecological disorders
Role of GnRH agonist in benign gynaecological disordersRole of GnRH agonist in benign gynaecological disorders
Role of GnRH agonist in benign gynaecological disorders
Aboubakr Elnashar
 
ART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONSART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONS
Aboubakr Elnashar
 
Progestogens in obstetrics: Which type and route????
Progestogens in obstetrics: Which type and route????Progestogens in obstetrics: Which type and route????
Progestogens in obstetrics: Which type and route????
Aboubakr Elnashar
 
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Lifecare Centre
 
OHSS: Prediction and prevention in non IVF cycles
OHSS:  Prediction and prevention in  non IVF cyclesOHSS:  Prediction and prevention in  non IVF cycles
OHSS: Prediction and prevention in non IVF cycles
Aboubakr Elnashar
 
Uses of of N-acetyl Cysteine in Medicine, obstetrics, gynecology and inferti...
Uses of  of N-acetyl Cysteine in Medicine, obstetrics, gynecology and inferti...Uses of  of N-acetyl Cysteine in Medicine, obstetrics, gynecology and inferti...
Uses of of N-acetyl Cysteine in Medicine, obstetrics, gynecology and inferti...
Aboubakr Elnashar
 
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVFCURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
Aboubakr Elnashar
 
Uses of aromatase inhibitors in gynecology
Uses of   aromatase inhibitors   in gynecologyUses of   aromatase inhibitors   in gynecology
Uses of aromatase inhibitors in gynecology
Aboubakr Elnashar
 
Use of N-acetyl Cysteine in ovulation induction
Use of N-acetyl Cysteine  in ovulation inductionUse of N-acetyl Cysteine  in ovulation induction
Use of N-acetyl Cysteine in ovulation induction
Aboubakr Elnashar
 
what is new in controlled ovarian stimulation?
what is new in controlled ovarian stimulation?what is new in controlled ovarian stimulation?
what is new in controlled ovarian stimulation?
Aboubakr Elnashar
 
Ovarian Factor Infertility
Ovarian Factor InfertilityOvarian Factor Infertility
Ovarian Factor Infertility
Aboubakr Elnashar
 

What's hot (20)

Aromatase inhibitors in infertility
Aromatase inhibitors in infertilityAromatase inhibitors in infertility
Aromatase inhibitors in infertility
 
Progestogens in obstetrics: Which type and route????
Progestogens in obstetrics: Which type and route????Progestogens in obstetrics: Which type and route????
Progestogens in obstetrics: Which type and route????
 
Clomiphene citrate or aromatase inhibitors for superovulation in women with u...
Clomiphene citrate or aromatase inhibitors for superovulation in women with u...Clomiphene citrate or aromatase inhibitors for superovulation in women with u...
Clomiphene citrate or aromatase inhibitors for superovulation in women with u...
 
Obesity and ART
Obesity and ARTObesity and ART
Obesity and ART
 
Clomiphene citrate adjunctives & alternatives
Clomiphene citrate  adjunctives & alternatives Clomiphene citrate  adjunctives & alternatives
Clomiphene citrate adjunctives & alternatives
 
Treatment of poor responders: Review of Systematic reviews 2016
Treatment of poor responders: Review of Systematic reviews 2016 Treatment of poor responders: Review of Systematic reviews 2016
Treatment of poor responders: Review of Systematic reviews 2016
 
Prediction of pregnancy outcome after ICSI
Prediction  of pregnancy outcome  after ICSIPrediction  of pregnancy outcome  after ICSI
Prediction of pregnancy outcome after ICSI
 
The Role of Aromatase Inhibitors in Assisted Reproductive Technologies
The Role of Aromatase Inhibitors in Assisted Reproductive TechnologiesThe Role of Aromatase Inhibitors in Assisted Reproductive Technologies
The Role of Aromatase Inhibitors in Assisted Reproductive Technologies
 
Progesterone rise on the day of hcg administration (ppremature luteinization)...
Progesterone rise on the day of hcg administration (ppremature luteinization)...Progesterone rise on the day of hcg administration (ppremature luteinization)...
Progesterone rise on the day of hcg administration (ppremature luteinization)...
 
Role of GnRH agonist in benign gynaecological disorders
Role of GnRH agonist in benign gynaecological disordersRole of GnRH agonist in benign gynaecological disorders
Role of GnRH agonist in benign gynaecological disorders
 
ART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONSART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONS
 
Progestogens in obstetrics: Which type and route????
Progestogens in obstetrics: Which type and route????Progestogens in obstetrics: Which type and route????
Progestogens in obstetrics: Which type and route????
 
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
 
OHSS: Prediction and prevention in non IVF cycles
OHSS:  Prediction and prevention in  non IVF cyclesOHSS:  Prediction and prevention in  non IVF cycles
OHSS: Prediction and prevention in non IVF cycles
 
Uses of of N-acetyl Cysteine in Medicine, obstetrics, gynecology and inferti...
Uses of  of N-acetyl Cysteine in Medicine, obstetrics, gynecology and inferti...Uses of  of N-acetyl Cysteine in Medicine, obstetrics, gynecology and inferti...
Uses of of N-acetyl Cysteine in Medicine, obstetrics, gynecology and inferti...
 
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVFCURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
CURRENT EVIDENCE ON MEDICAL ADD-ONS IN IVF
 
Uses of aromatase inhibitors in gynecology
Uses of   aromatase inhibitors   in gynecologyUses of   aromatase inhibitors   in gynecology
Uses of aromatase inhibitors in gynecology
 
Use of N-acetyl Cysteine in ovulation induction
Use of N-acetyl Cysteine  in ovulation inductionUse of N-acetyl Cysteine  in ovulation induction
Use of N-acetyl Cysteine in ovulation induction
 
what is new in controlled ovarian stimulation?
what is new in controlled ovarian stimulation?what is new in controlled ovarian stimulation?
what is new in controlled ovarian stimulation?
 
Ovarian Factor Infertility
Ovarian Factor InfertilityOvarian Factor Infertility
Ovarian Factor Infertility
 

Viewers also liked

ART: Management of associated conditions
ART: Management of  associated conditionsART: Management of  associated conditions
ART: Management of associated conditions
Aboubakr Elnashar
 
Gonadotrpin ovarian stimulation
Gonadotrpin ovarian stimulationGonadotrpin ovarian stimulation
Gonadotrpin ovarian stimulation
Aboubakr Elnashar
 
Patient preparation before IVF
Patient preparation before IVFPatient preparation before IVF
Patient preparation before IVF
Aboubakr Elnashar
 
Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008
Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008
Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008
Aboubakr Elnashar
 
VITAMIN AND MINERAL SUPPLEMENTATION DURING PREGNANCY
VITAMIN AND MINERAL SUPPLEMENTATION DURING PREGNANCYVITAMIN AND MINERAL SUPPLEMENTATION DURING PREGNANCY
VITAMIN AND MINERAL SUPPLEMENTATION DURING PREGNANCY
Aboubakr Elnashar
 
HOW TO REDUCE CS RATES?
HOW TO REDUCE CS RATES?HOW TO REDUCE CS RATES?
HOW TO REDUCE CS RATES?
Aboubakr Elnashar
 
Retained placenta
Retained placenta Retained placenta
Retained placenta
Aboubakr Elnashar
 
Prediction of pregnancy outcome and multiple gestation by measurement of seru...
Prediction of pregnancy outcome and multiple gestation by measurement of seru...Prediction of pregnancy outcome and multiple gestation by measurement of seru...
Prediction of pregnancy outcome and multiple gestation by measurement of seru...
Aboubakr Elnashar
 
Hypothyroidism During pregnancy
Hypothyroidism During pregnancyHypothyroidism During pregnancy
Hypothyroidism During pregnancy
Aboubakr Elnashar
 
Postdate pregnancy
Postdate pregnancyPostdate pregnancy
Postdate pregnancy
Aboubakr Elnashar
 
Antiphospholipid syndrome
Antiphospholipid syndromeAntiphospholipid syndrome
Antiphospholipid syndrome
Aboubakr Elnashar
 
ROLE OF CABERGOLIN IN MANAGEMENT OF OHSS
ROLE OF  CABERGOLIN  IN MANAGEMENT OF  OHSSROLE OF  CABERGOLIN  IN MANAGEMENT OF  OHSS
ROLE OF CABERGOLIN IN MANAGEMENT OF OHSS
Aboubakr Elnashar
 
Thyroid function: Female fertility & ART
Thyroid function:  Female fertility & ARTThyroid function:  Female fertility & ART
Thyroid function: Female fertility & ART
Aboubakr Elnashar
 
Hypothyroidism and Menstruation, Repeated miscarriage, Infertility, ART
Hypothyroidism and  Menstruation, Repeated miscarriage,    Infertility,  ARTHypothyroidism and  Menstruation, Repeated miscarriage,    Infertility,  ART
Hypothyroidism and Menstruation, Repeated miscarriage, Infertility, ART
Aboubakr Elnashar
 
Evaluation of male infertility
Evaluation of male infertilityEvaluation of male infertility
Evaluation of male infertility
Aboubakr Elnashar
 
The Management of Uterine Fibroids in Women With Otherwise Unexplained Infer...
The Management of Uterine Fibroids  in Women With Otherwise Unexplained Infer...The Management of Uterine Fibroids  in Women With Otherwise Unexplained Infer...
The Management of Uterine Fibroids in Women With Otherwise Unexplained Infer...
Aboubakr Elnashar
 
THIRD AND FOURTH DEGREE TEARS
THIRD AND FOURTH DEGREE TEARSTHIRD AND FOURTH DEGREE TEARS
THIRD AND FOURTH DEGREE TEARS
Aboubakr Elnashar
 
EPILEPSY AND PREGNANCY
EPILEPSY AND PREGNANCYEPILEPSY AND PREGNANCY
EPILEPSY AND PREGNANCY
Aboubakr Elnashar
 
Hyperthyroidism During pregnancy
Hyperthyroidism During pregnancyHyperthyroidism During pregnancy
Hyperthyroidism During pregnancy
Aboubakr Elnashar
 
Threatened and unexplained repeated miscarriages
Threatened and  unexplained repeated miscarriagesThreatened and  unexplained repeated miscarriages
Threatened and unexplained repeated miscarriages
Aboubakr Elnashar
 

Viewers also liked (20)

ART: Management of associated conditions
ART: Management of  associated conditionsART: Management of  associated conditions
ART: Management of associated conditions
 
Gonadotrpin ovarian stimulation
Gonadotrpin ovarian stimulationGonadotrpin ovarian stimulation
Gonadotrpin ovarian stimulation
 
Patient preparation before IVF
Patient preparation before IVFPatient preparation before IVF
Patient preparation before IVF
 
Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008
Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008
Induction of Labour: SOGC, 2013 WHO, 2011 NICE, 2008
 
VITAMIN AND MINERAL SUPPLEMENTATION DURING PREGNANCY
VITAMIN AND MINERAL SUPPLEMENTATION DURING PREGNANCYVITAMIN AND MINERAL SUPPLEMENTATION DURING PREGNANCY
VITAMIN AND MINERAL SUPPLEMENTATION DURING PREGNANCY
 
HOW TO REDUCE CS RATES?
HOW TO REDUCE CS RATES?HOW TO REDUCE CS RATES?
HOW TO REDUCE CS RATES?
 
Retained placenta
Retained placenta Retained placenta
Retained placenta
 
Prediction of pregnancy outcome and multiple gestation by measurement of seru...
Prediction of pregnancy outcome and multiple gestation by measurement of seru...Prediction of pregnancy outcome and multiple gestation by measurement of seru...
Prediction of pregnancy outcome and multiple gestation by measurement of seru...
 
Hypothyroidism During pregnancy
Hypothyroidism During pregnancyHypothyroidism During pregnancy
Hypothyroidism During pregnancy
 
Postdate pregnancy
Postdate pregnancyPostdate pregnancy
Postdate pregnancy
 
Antiphospholipid syndrome
Antiphospholipid syndromeAntiphospholipid syndrome
Antiphospholipid syndrome
 
ROLE OF CABERGOLIN IN MANAGEMENT OF OHSS
ROLE OF  CABERGOLIN  IN MANAGEMENT OF  OHSSROLE OF  CABERGOLIN  IN MANAGEMENT OF  OHSS
ROLE OF CABERGOLIN IN MANAGEMENT OF OHSS
 
Thyroid function: Female fertility & ART
Thyroid function:  Female fertility & ARTThyroid function:  Female fertility & ART
Thyroid function: Female fertility & ART
 
Hypothyroidism and Menstruation, Repeated miscarriage, Infertility, ART
Hypothyroidism and  Menstruation, Repeated miscarriage,    Infertility,  ARTHypothyroidism and  Menstruation, Repeated miscarriage,    Infertility,  ART
Hypothyroidism and Menstruation, Repeated miscarriage, Infertility, ART
 
Evaluation of male infertility
Evaluation of male infertilityEvaluation of male infertility
Evaluation of male infertility
 
The Management of Uterine Fibroids in Women With Otherwise Unexplained Infer...
The Management of Uterine Fibroids  in Women With Otherwise Unexplained Infer...The Management of Uterine Fibroids  in Women With Otherwise Unexplained Infer...
The Management of Uterine Fibroids in Women With Otherwise Unexplained Infer...
 
THIRD AND FOURTH DEGREE TEARS
THIRD AND FOURTH DEGREE TEARSTHIRD AND FOURTH DEGREE TEARS
THIRD AND FOURTH DEGREE TEARS
 
EPILEPSY AND PREGNANCY
EPILEPSY AND PREGNANCYEPILEPSY AND PREGNANCY
EPILEPSY AND PREGNANCY
 
Hyperthyroidism During pregnancy
Hyperthyroidism During pregnancyHyperthyroidism During pregnancy
Hyperthyroidism During pregnancy
 
Threatened and unexplained repeated miscarriages
Threatened and  unexplained repeated miscarriagesThreatened and  unexplained repeated miscarriages
Threatened and unexplained repeated miscarriages
 

Similar to Effective interventions in ART An overview of Cochrane Reviews 2015

An Evidence Based ART Cochrane Systematic Reviews 2015
An Evidence Based ART Cochrane Systematic Reviews 2015An Evidence Based ART Cochrane Systematic Reviews 2015
An Evidence Based ART Cochrane Systematic Reviews 2015
Aboubakr Elnashar
 
Worse pregnancy outcomes with low dose human chorionic
Worse pregnancy outcomes with low dose human chorionicWorse pregnancy outcomes with low dose human chorionic
Worse pregnancy outcomes with low dose human chorionic
Laith Alasadi
 
ART: Factors affecting success
ART:  Factors affecting  success ART:  Factors affecting  success
ART: Factors affecting success
Aboubakr Elnashar
 
UOG Journal Club: Dydrogesterone versus progesterone for luteal-phase support...
UOG Journal Club: Dydrogesterone versus progesterone for luteal-phase support...UOG Journal Club: Dydrogesterone versus progesterone for luteal-phase support...
UOG Journal Club: Dydrogesterone versus progesterone for luteal-phase support...
International Society of Ultrasound in Obstetrics and Gynecology (ISUOG)
 
Ovarian hyper stimulation syndrome ohss
Ovarian hyper stimulation syndrome ohssOvarian hyper stimulation syndrome ohss
Ovarian hyper stimulation syndrome ohss
Dr.Laxmi Agrawal Shrikhande
 
Cochrane
CochraneCochrane
Cochrane
Hesham Al-Inany
 
PERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHAR
PERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHARPERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHAR
PERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHAR
Aboubakr Elnashar
 
L3 alviggi lh bucarest 2013 (1)
L3 alviggi lh bucarest 2013 (1)L3 alviggi lh bucarest 2013 (1)
L3 alviggi lh bucarest 2013 (1)t7260678
 
L3 alviggi lh bucarest 2013
L3 alviggi lh bucarest 2013L3 alviggi lh bucarest 2013
L3 alviggi lh bucarest 2013t7260678
 
POOR RESPONDERS: Minimal Vs. Maximal stimulation
POOR RESPONDERS: Minimal Vs. Maximal stimulationPOOR RESPONDERS: Minimal Vs. Maximal stimulation
POOR RESPONDERS: Minimal Vs. Maximal stimulation
Aboubakr Elnashar
 
Adjuvant therapy
Adjuvant therapyAdjuvant therapy
Adjuvant therapy
Hesham Al-Inany
 
L10 key slides sunkara
L10 key slides sunkaraL10 key slides sunkara
L10 key slides sunkarat7260678
 
L10 key slides sunkara (1)
L10 key slides sunkara (1)L10 key slides sunkara (1)
L10 key slides sunkara (1)t7260678
 
L10 key slides sunkara
L10 key slides sunkaraL10 key slides sunkara
L10 key slides sunkarat7260678
 
L10 key slides sunkara
L10 key slides sunkaraL10 key slides sunkara
L10 key slides sunkara鋒博 蔡
 
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
Sujoy Dasgupta
 
ART options for poor responders.pdf
ART options for poor responders.pdfART options for poor responders.pdf
ART options for poor responders.pdf
Marmara University School of Medicine
 
Unexplained infertility: oral fertility drugs
Unexplained infertility:  oral fertility drugsUnexplained infertility:  oral fertility drugs
Unexplained infertility: oral fertility drugs
Aboubakr Elnashar
 
Luteal Phase Support In IVF
Luteal Phase Support In IVFLuteal Phase Support In IVF
Luteal Phase Support In IVF
Abdulmagid Sarhan
 
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...Sandro Esteves
 

Similar to Effective interventions in ART An overview of Cochrane Reviews 2015 (20)

An Evidence Based ART Cochrane Systematic Reviews 2015
An Evidence Based ART Cochrane Systematic Reviews 2015An Evidence Based ART Cochrane Systematic Reviews 2015
An Evidence Based ART Cochrane Systematic Reviews 2015
 
Worse pregnancy outcomes with low dose human chorionic
Worse pregnancy outcomes with low dose human chorionicWorse pregnancy outcomes with low dose human chorionic
Worse pregnancy outcomes with low dose human chorionic
 
ART: Factors affecting success
ART:  Factors affecting  success ART:  Factors affecting  success
ART: Factors affecting success
 
UOG Journal Club: Dydrogesterone versus progesterone for luteal-phase support...
UOG Journal Club: Dydrogesterone versus progesterone for luteal-phase support...UOG Journal Club: Dydrogesterone versus progesterone for luteal-phase support...
UOG Journal Club: Dydrogesterone versus progesterone for luteal-phase support...
 
Ovarian hyper stimulation syndrome ohss
Ovarian hyper stimulation syndrome ohssOvarian hyper stimulation syndrome ohss
Ovarian hyper stimulation syndrome ohss
 
Cochrane
CochraneCochrane
Cochrane
 
PERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHAR
PERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHARPERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHAR
PERFORMING EMBRYO TRANSFER. ABOUBAKR ELNASHAR
 
L3 alviggi lh bucarest 2013 (1)
L3 alviggi lh bucarest 2013 (1)L3 alviggi lh bucarest 2013 (1)
L3 alviggi lh bucarest 2013 (1)
 
L3 alviggi lh bucarest 2013
L3 alviggi lh bucarest 2013L3 alviggi lh bucarest 2013
L3 alviggi lh bucarest 2013
 
POOR RESPONDERS: Minimal Vs. Maximal stimulation
POOR RESPONDERS: Minimal Vs. Maximal stimulationPOOR RESPONDERS: Minimal Vs. Maximal stimulation
POOR RESPONDERS: Minimal Vs. Maximal stimulation
 
Adjuvant therapy
Adjuvant therapyAdjuvant therapy
Adjuvant therapy
 
L10 key slides sunkara
L10 key slides sunkaraL10 key slides sunkara
L10 key slides sunkara
 
L10 key slides sunkara (1)
L10 key slides sunkara (1)L10 key slides sunkara (1)
L10 key slides sunkara (1)
 
L10 key slides sunkara
L10 key slides sunkaraL10 key slides sunkara
L10 key slides sunkara
 
L10 key slides sunkara
L10 key slides sunkaraL10 key slides sunkara
L10 key slides sunkara
 
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
Diagnosis and Management of Poor Ovarian Reserve : Evidence & Practice
 
ART options for poor responders.pdf
ART options for poor responders.pdfART options for poor responders.pdf
ART options for poor responders.pdf
 
Unexplained infertility: oral fertility drugs
Unexplained infertility:  oral fertility drugsUnexplained infertility:  oral fertility drugs
Unexplained infertility: oral fertility drugs
 
Luteal Phase Support In IVF
Luteal Phase Support In IVFLuteal Phase Support In IVF
Luteal Phase Support In IVF
 
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
 

More from Aboubakr Elnashar

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
Aboubakr Elnashar
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
Aboubakr Elnashar
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
Aboubakr Elnashar
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
Aboubakr Elnashar
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
Aboubakr Elnashar
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
Aboubakr Elnashar
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
Aboubakr Elnashar
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
Aboubakr Elnashar
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
Aboubakr Elnashar
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
Aboubakr Elnashar
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
Aboubakr Elnashar
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
Aboubakr Elnashar
 
Female infertility
Female infertility Female infertility
Female infertility
Aboubakr Elnashar
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
Aboubakr Elnashar
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
Aboubakr Elnashar
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
Aboubakr Elnashar
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
Aboubakr Elnashar
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
Aboubakr Elnashar
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
Aboubakr Elnashar
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
Aboubakr Elnashar
 

More from Aboubakr Elnashar (20)

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
Female infertility
Female infertility Female infertility
Female infertility
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 

Recently uploaded

The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 

Recently uploaded (20)

The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 

Effective interventions in ART An overview of Cochrane Reviews 2015

  • 1. Effective interventions in ART An overview of Cochrane Reviews 2015 Aboubakr Elnashar Benha university Hospital, Egypt ABOUBAKR ELNASHAR
  • 2. Searching for the Best Evidence ABOUBAKR ELNASHAR
  • 3. The Cochrane Collaboration  International collaboration  Prepares, maintains, and disseminates systematic reviews  Diverse internal structure (Review Groups, Centres, Fields, Methods Groups, the Consumer Network) Cochrane Library  The current resource with the highest methodological rigor  $235/year or abstracts only  www.cochrane.org ABOUBAKR ELNASHAR
  • 4. Increasingly, couples are turning to ART for help with conceiving and ultimately giving birth to a healthy live baby of their own. Fertility treatments are complex, and each ART cycle consists of several steps. If one of the steps is incorrectly applied, the stakes are high as conception may not occur. With this in mind, it is important that each step of the ART cycle is supported by good evidence from well-designed studies. ABOUBAKR ELNASHAR
  • 5. 95 systematic reviews published in The Cochrane Library up to July 2015 were included. All were high quality. 32 reviews identified interventions that were effective (n = 19) or promising (n = 13) 14 reviews identified interventions that were either ineffective (n = 2) or possibly ineffective (n = 12) 13 reviews were unable to draw conclusions due to lack of evidence. (Farquhar et al, 2015) ABOUBAKR ELNASHAR
  • 6. Results • Effective interventions: indicating that the review found evidence of effectiveness (or improved safety) for an intervention. ABOUBAKR ELNASHAR
  • 7. • Ineffective interventions: indicating that the review found evidence of lack of effectiveness (or reduced safety) for an intervention. ABOUBAKR ELNASHAR
  • 8. 1. Pre-ART and adjuvant strategies Effective interventions • Endometrial injury in women undergoing ART: performed in the month prior to ovulation induction: increase both LBR or OPR and CPR (moderate quality evidence). •No evidence of a difference between the groups in miscarriage, multiple pregnancy or bleeding rates. •Endometrial injury on the day of OR: lower LBR or OPL (low quality evidence). (Nastri , 2015) ABOUBAKR ELNASHAR
  • 9. • Growth hormone for IVF: in poor responders: significant improvement in LBR (moderate quality evidence). (Duffy 2010) • Metformin treatment before and during IVF or ICSI in women with PCOS: No conclusive evidence for improved LBR (low quality evidence). Met increased CPR and decreased risk of OHSS (moderate quality evidence). (Tso, 2014) ABOUBAKR ELNASHAR
  • 10. • Surgical treatment for hydrosalpix: laparoscopic tubal occlusion is an alternative to laparoscopic salpingectomy in improving IVF PR (moderate quality evidence). (Johnson, 2010) ABOUBAKR ELNASHAR
  • 11. 2. Down-regulation with agonists or antagonists Effective interventions • GnRHa protocols for pituitary suppression in ART: CPR was higher when GnRHa was used in a long protocol as compared to a short or ultra-short protocol (low quality evidence). (Maheshwari 2011) • GnRHan for ART: Antagonist compared with long GnRHa protocols: reduction in OHSS No evidence of a difference in LBR (moderate quality evidence). (Al-Inany 2011) ABOUBAKR ELNASHAR
  • 12. • Long-term pituitary down-regulation before IVF for women with endometriosis: GnRHa for a period of 3-6 months prior to IVF or ICSI: increased CPR (very low quality evidence). (Sallam, 2006) ABOUBAKR ELNASHAR
  • 13. 3. Ovarian stimulation Effective interventions • Rec vs urinary gonadotrophin for ovarian stimulation in ART: all available gonadotrophins were equally effective and safe. Choice will depend upon: availability of the product convenience of its use associated costs. Any specific differences are likely to be too small to justify further research (high quality evidence). (van Wely 2011) ABOUBAKR ELNASHAR
  • 14. • Long-acting FSH vs daily FSH for ART: medium dose (150 to 180 μg) of long-acting FSH appeared to be a safe and as effective as daily FSH in women with unexplained subfertility. low dose (60 to 120 μg) of long-acting FSH compared to daily FSH: Reduced LBR (moderate quality evidence). (Pouwer, 2015) ABOUBAKR ELNASHAR
  • 15. 4. Ovulation triggering Effective interventions • Rec Vs. u hCG for final oocyte maturation triggering in IVF and ICSI cycles: u hCG remains the best choice for final oocyte maturation triggering in ART {availability and cost} (moderate quality evidence). (Youssef, 2011) ABOUBAKR ELNASHAR
  • 16. • GnRHa Vs. hCG for oocyte triggering in antagonist ART cycles: GnRHa: lower LBR reduced OPR higher miscarriage rate reduction in OHSS rates A trade off between benefits and harms (moderate quality evidence). (Youssef , 2014) ABOUBAKR ELNASHAR
  • 17. 5. Oocyte retrieval Effective interventions • Pain relief: 5 different categories of conscious sedation and analgesia appeared to be acceptable and were associated with a high degree of satisfaction in women. The optimal method may be individualised depending on preferences of the women and their clinicians resource availability (very low quality evidence). (Kwan , 2013) ABOUBAKR ELNASHAR
  • 18. Ineffective interventions • Follicular flushing: No improved C or OPR No increase in oocyte yield. Increase operative time More opiate analgesia (moderate quality evidence). (Wongtra-ngan 2010) ABOUBAKR ELNASHAR
  • 19. 6. Laboratory phase Effective interventions • Low oxygen concentrations for embryo culture in ART: :an increase in LBR (moderate quality evidence). (Bontekoe , 2012) ABOUBAKR ELNASHAR
  • 20. Ineffective interventions • Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies): using fluorescent in situ hybridization significantly decreased LBR in women of advanced maternal age and those with repeated IVF failure Trials in which PGS was offered to women with a good prognosis suggested similar outcomes (moderate quality evidence). (Twisk, 2006) ABOUBAKR ELNASHAR
  • 21. 7. Embryo transfer Effective interventions • Ultrasound versus ’clinical touch’ for catheter guidance: significant increase in CPR (low quality evidence). (Brown, 2010) ABOUBAKR ELNASHAR
  • 22. • Adherence compounds in ET media for ART: use of hyaluronic acid. improved LBR and CPR with the Increase Multiple pregnancy rates (moderate quality evidence). (Bontekoe, 2014) ABOUBAKR ELNASHAR
  • 23. • Number of embryos for transfer: single embryo transfer compared with double embryo transfer  LBR was lower  fewer multiple pregnancies (high quality evidence). cumulative LBR associated with single embryo transfer followed by a single frozen and thawed ET was comparable with that after one cycle of double embryo transfer (low quality evidence). (Pandian, 2013) ABOUBAKR ELNASHAR
  • 24. 8. Luteal phase support Effective interventions • LPS: Progesterone appears to be the best method, higher LBR and OPR than placebo lower rates of OHSS than hCG. Addition of one or more doses of GnRHa to progesterone: higher LBR and OPR than progesterone alone. ABOUBAKR ELNASHAR
  • 25. Addition of oestrogen or hCG did not improve outcomes, and hCG was associated with higher risk of OHSS. The route of progesterone administration did not seem to matter (quality of evidence low for most comparisons). (van der Linden, 2015) ABOUBAKR ELNASHAR
  • 26. 9. Prevention of OHSS Effective interventions •hydroxyethyl starch decreased the incidence of severe OHSS (very low quality evidence) (Youssef 2011) • Cabergoline: reduce the risk of OHSS in high risk women, especially for moderate OHSS did not affect CPR or miscarriage rates No increased risk of other adverse events (low quality evidence). (Tang, 2012) ABOUBAKR ELNASHAR
  • 27. • GnRHan compared with long GnRHa protocols: reduction in OHSS no evidence of a difference in LBR (moderate quality evidence). (Al-Inany, 2011) ABOUBAKR ELNASHAR
  • 28. • GnRHa versus hCG for oocyte triggering in antagonist ART cycles: lower LBR reduced OPR higher miscarriage rate reduction in OHSS rates a trade off between benefits and harms (moderate quality evidence). (Youssef , 2014) ABOUBAKR ELNASHAR
  • 29. C O N C L U S I O N S This overview provides the most up to date evidence on ART cycles from systematic reviews of RCT Fertility treatments are costly and the stakes are high. Best practice requires using the best available evidence to optimise outcomes. The evidence from this overview could be used to develop clinical practice guidelines and protocols for use in daily clinical practice, in order to improve LBR and reduce rates of multiple pregnancy, cycle cancellation and OHSS. ABOUBAKR ELNASHAR